Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Leendert Trouw benoemd tot hoogleraar Complementbiologie en -therapie
feb 2023 | Immuuntherapie, RA, Tuberculose